Expert Discusses Pulmonary Nodules and Lung Cancer Screening

OSUWexnerbloglogo2014 Expert Discusses Pulmonary Nodules and Lung Cancer Screening. Today on MedNet21, we are going to help you use the chest CT in your own clinical practice in order to save lives. My guest is pulmonologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Mike Wert.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: develop an evidence-based approach to the management of solitary pulmonary nodules; and understand the evidence behind and the importance of lung cancer screening in high-risk patients.

You’ll also learn about the following:

  • Efficacy of lung cancer screening
  • Challenges with lung cancer screening?

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Bronchiectasis

OSUWexnerbloglogo2014 CME Webcast Discusses Bronchiectasis. Antibiotics are now readily available but bronchiectasis is still a common problem. It is just that the most common causes of bronchiectasis have changed. Today on MedNet, we are going to take a look at the etiology and treatment of bronchiectasis. We’re pleased to welcome pulmonologist and Assistant Professor of Internal Medicine, Dr. Sarah Tapyrik.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize common radiographical patterns of bronchiectasis on CT imaging; and be familiar with underlying causes of bronchiectasis to help guide testing for individual patients.

You’ll also learn about the following:

  • Clinical presentation of bronchiectasis
  • Treatment of bronchiectasis
  • Dornase alpha
  • Vaccinations and bronchiectasis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Approach to Thrombocytopenia

OSUWexnerbloglogo2014 CME Webcast Discusses Approach to Thrombocytopenia. Joining our moderator today to tell us all about the approach to thrombocytopenia is hematologist and Professor of Internal Medicine, Dr. Spero Cataland. And also nephrologist and Associate Professor of Internal Medicine, Dr. Samir Parikh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: APPLY a practical approach to the differential diagnosis of thrombocytopenia associated with acute kidney injury; DIFFERENTIATE the causes of thrombotic microangiopathy (TMA) and their potential for causing renal failure; DIFFERENTIATE the more common causes of thrombocytopenia from the rare and serious causes of thrombocytopenia that require a specific management strategy; and RECOGNIZE and diagnose the more causes of thrombocytopenia (HIT, ITP, and TTP) that require rapid identification and specialized treatment.

You’ll also learn about the following:

  • Common causes of thrombocytopenia
  • New treatments for thrombocytopenia
  • Immune thrombocytopenic purpura (ITP) treatment
  • Treatment strategies for heparin-induced thrombocytopenia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Webcast Discusses Obstructive Sleep Apnea

OSUWexnerbloglogo2014 On-line Webcast Discusses Obstructive Sleep Apnea. Obstructive sleep apnea is incredibly common and destined to only become more common in the future. On this CME webcast, we are going to learn about the diagnosis and treatment of sleep apnea. Joining us today are sleep medicine specialists from the Ohio State University. Dr. Steven Holfinger is an Assistant Professor of Internal Medicine and Dr. Madelyn Rosenthal is also an Assistant Professor of Internal Medicine, both from the Division of Pulmonary, Critical Care, and Sleep Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: APPROPRIATELY screen patients in a primary care setting; DIAGNOSE sleep apnea with appropriate testing; UNDERSTAND the important factors that should be addressed at each obstructive sleep apnea follow up visit; and RECOGNIZE and troubleshoot common factors that affect PAP adherence, residual daytime sleepiness and nasal congestion.

You’ll also learn about the following:

  • Sleep apnea risk factors
  • Pre-operative screening for obstructive sleep apnea
  • Mask options
  • Dental devices and surgery for obstructive sleep apnea
  • Management of central sleep apnea
  • Auto-CPAP machines
  • The economics of CPAP equipment
  • Treatment of snoring

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Webcast Discusses Chronic Lymphocytic Leukemia

OSUWexnerbloglogo2014 On-line Webcast Discusses Chronic Lymphocytic Leukemia. On this CME webcast, we’re going to bring you up to date on the latest about chronic lymphocytic leukemia, or CLL. Joining us is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Kerry Rogers. And also hematologist and Associate Professor of Internal Medicine from OSU and the James Cancer Hospital, Dr. Jennifer Woyach.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: CLL is a chronic lymphoid malignancy which does not need treatment at diagnosis if asymptomatic and has a survival of many years; CLL patients are at higher risk for second cancers or infection so it is important so all CLL patients with CLL should get all age appropriate cancer screenings and vaccinations; UNDERSTAND indications for treatment in CLL and the rationale for the watch and wait approach; and UNDERSTAND some serious side effects that can occur with oral targeted therapies in CLL.

You’ll also learn about the following:

  • Risks for CLL
  • Current approach to treatment of CLL
  • Roles and limitations of automated WBC differentials
  • Initial approach to lymphocytosis
  • Emerging trends in first line treatment of CLL
  • Role of age of the patient in therapeutic decision making
  • Stem cell transplants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.